Oxygen Biotherapeutics soars on heavy volume

Oxygen Biotherapeutics (OXBT +57.9%) adds to last week's gains, rising sharply on twice its average 10-day volume.

With today's action the shares are up some 234% since last Wednesday when the company reported the publication of a meta-analysis of aggregated levosimendan data.

Comments (1)
  • jsutcliffe
    , contributor
    Comment (1) | Send Message
    wow... how long can this hold out?
    4 Nov 2013, 12:22 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs